Video
3 Feb 2025

Lightning Talk: Ophthalmic Drug Delivery Latest Development

The development of new ophthalmic drop delivery systems represents a crucial challenge when it comes to meeting the growing needs of eye disease treatment. Since the 1950s, these systems have evolved considerably, driven by both technological and regulatory advances. Technological innovation plays a central role in this field, with advances such as preservative-free multi-dose vials that improve tolerance in sensitive patients. Tomorrow, these innovations should translate into eco-designed systems, facilitating personalized and optimized treatments, while also improving patient compliance. In addition, the rise of new technologies such as nanotechnologies, biopolymers and digital devices is paving the way for a new generation of sustained-release systems.

Content provided by our supplier

TERUMO

  • Country/Region:
    Belgium
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
Manufacturer/Innovator
Primary activities
Medical Devices

Other Content from TERUMO (19)